Statistics
Publications
9
Citations
408
H-Index
9
Active since
1997
Lanlin Hu is an author at Sichuan Cancer Hospital specializing in oncology, medicine, and molecular oncology.
Publications per year
1997–2024
9
9
Cancer stem cells: a target for overcoming therapeutic resistance and relapse
Shuo Zhang, Rui Yang, Yujie Ouyang et al. · Cancer Biology and Medicine · 2024 · 27 citations · Full text
Medicine, Cancer Biology, Oncology +17
ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma
Ying Shi, Mengwan Wu, Yuyang Liu et al. · Frontiers in Oncology · 2021 · 24 citations · Full text
Medicine, Oncology, Pharmacology +17
HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing
Hong Wu, Yiqiang Liu, Q. Liu et al. · Science Advances · 2024 · 22 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 9